effects

United Nations experimental weight-loss drug from Eli Lilly & Co. produced the best results of any treatment to date, another boost to the company's efforts to tame the burgeoning obesity drug market. The obese patients they lose an average of 24.2% of their body weight, about 58 pounds, with the highest dose of the drug after 48 weeks, according to a study published Monday in the New England Journal of Medicine. A quarter of those given the highest dose lost 30% or more, the company-funded mid-stage trial revealed. "We haven't seen results like this before in a trial of less…